Announced Wed, 20 May · 19:43 IST

Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹14.45
prior close
₹14.49
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-0.3-0.2+8.6+5.5+6.5+4.8+5.1+3.1+3.7-2.4
Up moveDown movePending
AI summary

Tejnaksh Healthcare Ltd has informed BSE that its Board of Directors meeting is scheduled for May 30, 2026 at its Mumbai office. The primary agenda is to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026, covering both standalone and consolidated statements. The company also mentions that the trading window remains closed from March 27, 2026 until 48 hours after the results are declared, as per SEBI Insider Trading Regulations. This is a standard regulatory intimation required under SEBI (LODR) Regulations.

Likely market impact

This is a routine board meeting notice for annual financial results. No immediate impact on stock price, but investors should note the trading window closure until results are announced. Positive or negative signals will only be visible when results are published.